Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-16

Clinical Trial Update: Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of EGT0001442 in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EGT0001442

Snippet

Sponsor: Theracos | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2021-06-16